Global Craniomaxillofacial Devices Market by Type (CMF plate and Screw Fixation, Bone Graft Substitute, Temporomandibular Joint Replacement, and Others), By Application (Neurosurgery, orthogenetic and Dental Surgery, Plastic Surgery, and Others), By Material (Metal, Bioabsorbable material, Ceramic, and Others), By End-User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Report Overview

In 2022, the Global Craniomaxillofacial Devices Market Size was valued at USD 1.7 Billion and is expected to grow to USD 3.9 Billion in 2032. Between 2023 and 2032, this market is estimated to register the highest CAGR of 8.8%.

Craniomaxillofacial Devices are used in surgery for trauma injuries, facial treatments, and cranial disorders. The various types of systems are used in Craniomaxillofacial surgeries, including MF plate and screw fixation system, cranial flap fixation system, CMF distraction system, and thoracic fixation system. The presence of expensive Craniomaxillofacial surgeries that incorporate these devices and lack of awareness in developing regions may decrease the adaption of Craniomaxillofacial Devices.

Craniomaxillofacial surgeries deal with congenital and acquired skull deformities that are so much more complicated than other surgeries. This orthopedic surgery requires the participation of neurosurgeons, Plastic surgeons, and reconstruction surgery devices, making overall surgery costs very high.

Key Takeaways

• Market Growth: The market is expected to grow at a CAGR of 8.8% from 2023 to 2032, reaching USD 3.9 billion by 2032.
• Drivers: Increasing facial injury cases, especially in males, are propelling market growth.
• Restraints: High surgery costs and a lack of skilled surgeons hinder market expansion.
• Opportunities: Emerging economies like India and China offer growth opportunities with increased healthcare investments.
• Research and development and the rise of deep brain stimulation procedures drive market growth.
• The CMF distraction segment holds the largest market share, with applications in deformity correction, sports injuries, facial fractures, and more.
• Metallic implants are the dominant material due to their cost-effectiveness and rigidity, while bioabsorbable materials are expected to see the fastest growth.
• Hospitals are the primary end-users, with a significant number of patients and surgeons opting for Craniomaxillofacial surgeries.
• North America leads the global market, driven by advanced implants, awareness of corrective surgeries, and strong healthcare facilities.
• Asia Pacific is expected to experience the fastest growth, thanks to improving healthcare infrastructure and patient awareness.

Driving Factors

Increasing Prevalence of Facial Injuries and Fractures Estimated to Drive the Market Growth

The rise in the number of people suffering from cranial and maxillofacial injuries will become one of the major driving factors to increase the growth in the coming years. The increase in craniofacial fractures differs from region to region based on several demographic and socioeconomic factors.

In a recent research study, the frequency of craniomaxillofacial injuries is highest in males compared to other females. The increase in road accidents, motor vehicle accidents and spot injuries will play major roles in driving revenue growth. Increasing the frequency of minimally invasive trauma procedures instead of traditional therapy will help increase the demand and adaption rate of elective or reconstructive surgeries, which helps drive market growth.

The recent technological advancement in manufacturing devices and conducting surgeries will expand the craniomaxillofacial implant market growth in the coming years. The introduction of technologically advanced procedures. Robotic arm-assisted CMF surgery and bioabsorbable implants for cranial fixation are expected to drive the demand for CMF devices.

Restraints

The High Cost of Surgical Procedures and Other Factors Restraint the Growth of the Market

The Craniomaxillofacial devices market is facing some challenges, such as economic slowdown and treatment of extremely serious diseases preventing market growth. Also, Craniomaxillofacial surgeries are costly, and the lack of skilled surgeons restrains the market growth. The increasing competition and lack of awareness among patients are responsible for decreased demand for market growth. Factors such as multiple surgery requirements also restrain patients’ demand from adopting the surgery.

Opportunities

The Rising Demand for Less Expensive Surgeries Will Drive the Industry’s Expansion.

The Craniomaxillofacial Devices Market is also boosted due to growing healthcare industries in several emerging economies such as Brazil, India, South Africa, and China. The rapidly increasing geriatric population, rising per capita incomes, high patient volumes, and spiking awareness among individuals are driving the need for enhancing the Craniomaxillofacial Devices Market healthcare industries in these nations.

Therefore, the governments in these economies are increasing their investments to improve healthcare facilities & infrastructure. Owing to the high number of applications in healthcare industries, the rising investment in this industry is slated to offer growth opportunities in the market.

Trending Factors

To Bring New Devices into the Market and Rising Research on Craniomaxillofacial Devices is Expected to Propel the Growth of the Market Further. Due to increasing road accidents and cranial or brain fractures with the increasing demand for minimally invasive facial reconstruction, surgeries have become one of the key factors that help market growth. The growing awareness among individuals about the benefits of CMF devices strengthens the market growth.

The growing demand for deep brain stimulation procedures is catalysing the demand for CMF devices worldwide. CMF implants are used in these procedures to cover the skull after placing the electrode. However, introducing three-dimensional printed implants and titanium cranial fixation systems with a low risk of infection helps to enhance the market growth. Also, the increase in expenditure capacity, advanced development, and healthcare expenditure are the driving factors that help in the market growth.

Type Analysis

CMF Distraction Held the Largest Segment in Market

Based on product segment, the market is segmented into CMF plate and Screw Fixation, Bone Graft Substitute, Temporomandibular Joint Replacement, and others. CMF distraction held the largest market share during the forecast period due to increased surgical treatments such as deformity correction, sports injuries, facial fractures, orthognathic surgery, Neurosurgery & ENT, Tumor removal, cosmetic surgeries, and pediatric surgeries.

The bone graft substitute is anticipated to grow fastest during the market forecast period. Bone graft substitute is used to reconstruct bone defects and spine fusion. Also, the limited availability of donors shows the shortage of natural bone grafts which helps to increase demand for bone graft substitutes. Common synthetic bone substitutes include calcium sulfate, calcium phosphate ceramics, and bioactive glass ceramics.

The France-based biomatlants offer MBCP biphasic calcium phosphate synthetic bone graft substitute. It is approximately the same architecture as natural human bone and easily dissolves in the body, and it motivates bone formation by using phosphate and calcium ions management during surgery.

Application Analysis

Orthognathic & dental surgery Generate the Highest Revenue in the Application Segment

Based on application, the market is segmented into neurosurgery, plastic surgery, orthognathic & dental surgery, and others. The Orthognathic & dental surgery segment held the largest revenue due to its wide range of use to correct various minor and major dental and skeletal deformities. Neurosurgery was the fastest-growing segment to increase the incidence of trauma and spinal disorders requiring Cerebrospinal fluid (CSF) management during surgical procedures.

Surgeons perform craniotomies to gain greater access to the brain during neurosurgery. The craniotomies are used to treat trauma, infection in the brain, aneurysms, skull fractures, epilepsy, pressure in the brain after a stroke and severe injury, and to remove blood clots from a head injury. Also, the adaption of deep brain stimulation procedures is one of the key factors of this segment which helps this segment’s growth. The neurosurgical Application of cranial implants consists of skull surgery and otolaryngology procedures. The Medpor bio-absorbable implants are most commonly used for neurosurgery.

Material Analysis

Metallic Implants Show Largest Shares in the Global Market Material

Based on material, the market is segmented into metal, bioabsorbable material, ceramic, and others. The metallic implants held the largest shares in the overall material market segment, with the largest shares. Its features include the ability to provide rigid support to the fractures, lower corrosiveness at a very low cost than bioabsorbable materials, and higher market demand than other materials, which support market growth.

The materials are used in CMF surgery because they are physiologically and less corrosive, supporting the fractures. Metals like titanium and alloy are most commonly used for CMF surgery due to their advantages, such as being lightweight, providing strength, and having inert metallic properties. It is used in mandibular reconstruction. Bioabsorbable materials are expected to be the fastest growth during the forecast period, such as uses of these implants nullifying the chances of a second surgery, required for metallic implants, and easy adaptation in the body system. The technological advancements in CMF surgery, for example. Easily handled, degradable properties, biocompatible, and reliable factors estimated to boost the market growth.

End-User Analysis

Hospital Segment Holds the Dominant Craniomaxillofacial Devices Market Shares

Based on end-users, the market is segmented into hospitals, surgeons, ambulatory surgical centers, and others Hospital segment dominates the market due to the significant growth of patients in hospitals for craniomaxillofacial surgeries and an increase in the number of craniomaxillofacial surgeons. Also, the government invests in healthcare for advanced products and healthcare infrastructure.

Key Market Segments

Based on Type

• Bone Graft Substitute
• CMF plate and Screw Fixation
• Temporomandibular Joint Replacement
• Others

Based on Application

• Neurosurgery
• Orthognathic and Dental Surgery
• Plastic Surgery
• Others

Based on Material

• Metal
• Bio absorbable material
• Ceramic
• Others

Based on End-Users

• Hospitals
• Surgeons
• Ambulatory Surgery Centers
• Others

Regional Analysis

North America Dominates the Global Market During the Forecast Period

North America led the market segment in the market share due to the availability of technologically advanced implants and the increased number of craniomaxillofacial procedures. The factors such as increased awareness about abnormal correction surgeries and the presence of healthcare facilities are the main factors that contributed to market growth. Additionally, the government is taking initiatives to support and establish the American Society of craniofacial surgery.

Increasing awareness about the CMF surgeries increases the demand for CMF devices and boosts the market during the forecast period. Asia Pacific is estimated to have the fastest growth during the forecast period. The presence of new opportunities, consistently improving healthcare infrastructure, Advance development, and increasing patient awareness are the key factors that positively impact the lucrative growth of the craniomaxillofacial market in Asia Pacific.

Key Regions

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America
• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

Emerging key players are focused on various strategic policies to develop their respective businesses in foreign markets. Several Craniomaxillofacial Devices market companies are concentrating on expanding their existing operations and R&D facilities. Furthermore, businesses in the Craniomaxillofacial Devices market are developing new products and portfolio expansion strategies through investments, mergers, and acquisitions. In addition, several major players are now focusing on different marketing strategies, such as spreading awareness about natural ingredients and boosting the target products’ growth.

With many local and regional players, the market for human insulin is fragmented. Market players are subject to intense competition from top players, particularly those with strong brand recognition and high distribution networks. Companies have gained various expansion strategies such as partnerships and product launches to stay on top of the market.

Listed below are some of the most prominent Craniomaxillofacial Devices market players

Market Key Players

• DePuy Synthes (J&J),
• Stryker Corporation
• Medtronic
• Braun Melsungen AG
• Renishaw Plc.
• Medartis AG
• KLS Martin Group
• Xilloc Medical B.V
• Synimed
• Zimmer-Biomet
• Other key Players

Recent Developments

• February 2022: Biocon enrolled in a partnership with Viatris Inc. to obtain the biosimilar corporation of Viatris and supported its manufacturing and R&D facility to commercialize its efficiency.
• September 2021: Eli Lilly and Company lower the rate of the Lispro injection in the U.S., which supports patients to ease their out-of-pocket expenses and make it available at an affordable amount.
• In July 2021: The FDA approved India’s Biocon’s Semglee, a first-of-its-kind insulin product. Biocon Biologics, a pharmaceutical company based in Bengaluru, produces SEMGLEE, which is transposable with and biosimilar to Lantus. This long-acting insulin product has been approved in the United States.

Report Scope